← Leaderboards
Charles M. Morin
Laval University
$5,370,393
Attributed
$9,811,157
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,811,157 · 5
By mechanism
R01$4,482,240 · 3
UH3$3,477,195 · 1
UG3$1,851,722 · 1
Top collaborators
- Daniel J Buysse4 shared
- Julio Fernandez-Mendoza4 shared
- Elizabeth Devon Smith4 shared
- Jennifer L Taylor-Cousar4 shared
- Alexandros N Vgontzas4 shared
Most similar at Laval University
Same institution · by research overlap
- Michel G. Bergeron$6,627,801
- M R Murthy$384,984
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantSiteRandomizedSymptomsSamplingSleepSleeplessnessDisease RemissionHealth Care CostsCognitive TherapyModalityBaseBehavioralBehavior TherapyMental DisordersOutcome MeasureComorbidityQuality Of LifeResearch PersonnelFollow-UpMediatingImpairmentCognitiveAdult
Grant awards (19)
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,467,809
UH3 · FY2025 · HL
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$262,705
UH3 · FY2025 · HL
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,746,681
UH3 · FY2024 · HL
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial$1,851,722
UG3 · FY2023 · HL
2/2-Sequenced Therapies for Comorbid and Primary Insomnias$167,382
R01 · FY2015 · MH · contact PI
2/2-Sequenced Therapies for Comorbid and Primary Insomnias$176,159
R01 · FY2014 · MH · contact PI
2/2-Sequenced Therapies for Comorbid and Primary Insomnias$173,031
R01 · FY2013 · MH · contact PI
2/2-Sequenced Therapies for Comorbid and Primary Insomnias$181,376
R01 · FY2012 · MH · contact PI
Cognitive-Behavior Therapy for Insomnia: Component Analysis & Treatment Mechanism$346,469
R01 · FY2011 · MH · contact PI
2/2-Sequenced Therapies for Comorbid and Primary Insomnias$183,694
R01 · FY2011 · MH · contact PI
Cognitive-Behavior Therapy for Insomnia: Component Analysis & Treatment Mechanism$478,192
R01 · FY2010 · MH · contact PI
Cognitive-Behavior Therapy for Insomnia: Component Analysis & Treatment Mechanism$569,565
R01 · FY2009 · MH · contact PI
Cognitive-Behavior Therapy for Insomnia: Component Analysis & Treatment Mechanism$566,034
R01 · FY2008 · MH · contact PI
Cognitive-Behavior Therapy for Insomnia: Component Analysis & Treatment Mechanism$515,338
R01 · FY2007 · MH · contact PI
BEHAVIORAL AND PHARMACOLOGICAL TREATMENT FOR INSOMNIA$225,000
R01 · FY2005 · MH
BEHAVIORAL AND PHARMACOLOGICAL TREATMENT FOR INSOMNIA$225,000
R01 · FY2004 · MH
BEHAVIORAL AND PHARMACOLOGICAL TREATMENT FOR INSOMNIA$225,000
R01 · FY2003 · MH
BEHAVIORAL AND PHARMACOLOGICAL TREATMENT FOR INSOMNIA$225,000
R01 · FY2002 · MH
BEHAVIORAL AND PHARMACOLOGICAL TREATMENT FOR INSOMNIA$225,000
R01 · FY2001 · MH